Unknown

Dataset Information

Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrPC.


ABSTRACT: Prion diseases are infectious and fatal neurodegenerative diseases affecting humans and animals. Transmission is possible within and between species with zoonotic potential. Currently, no prophylaxis or treatment exists. Prions are composed of the misfolded isoform PrPSc of the cellular prion protein PrPC. Expression of PrPC is a prerequisite for prion infection, and conformational conversion of PrPC is induced upon its direct interaction with PrPSc. Inhibition of this interaction can abrogate prion propagation, and we have previously established peptide aptamers (PAs) binding to PrPC as new anti-prion compounds. Here, we mapped the interaction site of PA8 in PrP and modeled the complex in silico to design targeted mutations

SUBMITTER: Corda E 

PROVIDER: S-EPMC6132731 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature